The Prevalence of Dizziness and Vertigo in COVID-19 Patients: A Systematic Review

Clinical manifestations of COVID-19 include symptoms of vertigo and dizziness, which is rather unsurprising, since SARS-CoV-2 neurotropism may inflict a broad spectrum of neuropathic effects. The widespread nature of central and peripheral audiovestibular pathways suggests that there may be several...

Descripción completa

Detalles Bibliográficos
Autores principales: Korres, George, Kitsos, Dimitrios K., Kaski, Diego, Tsogka, Anthi, Giannopoulos, Sotirios, Giannopapas, Vasileios, Sideris, Giorgos, Tyrellis, Giorgos, Voumvourakis, Konstantine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313303/
https://www.ncbi.nlm.nih.gov/pubmed/35884754
http://dx.doi.org/10.3390/brainsci12070948
Descripción
Sumario:Clinical manifestations of COVID-19 include symptoms of vertigo and dizziness, which is rather unsurprising, since SARS-CoV-2 neurotropism may inflict a broad spectrum of neuropathic effects. The widespread nature of central and peripheral audiovestibular pathways suggests that there may be several probable pathophysiological mechanisms. The cytokine storm, CNS infiltration of the virus through ACE 2 receptors, and other systemic factors can be responsible for the significant number of COVID-19 patients reported to experience symptoms of vertigo and dizziness. In this paper, we present a systematic review of clinical studies reporting the detection of dizziness and vertigo as clinical manifestations of COVID-19 and discuss their etiopathogenesis.

Ejemplares similares